Source comparison
Sermorelin During Perimenopause: Dosing & Administration Comparison
Dose per injection 200–300mcg subcutaneous 100–500mcg depending on body weight and pituitary responsiveness Administer 30–60 minutes before bed on an empty stomach (3+ hours post-meal) to align with natural nocturnal GH pulse 200–300mcg nightly is the evidence
This comparison does not assign a generated winner or score.
- Dose per injection
- 200–300mcg subcutaneous
- 100–500mcg depending on body weight and pituitary responsiveness
- Administer 30–60 minutes before bed on an empty stomach (3+ hours post-meal) to align with natural nocturnal GH pulse
- 200–300mcg nightly is the evidence-backed starting range for perimenopausal women. Higher doses don't proportionally increase GH output due to receptor saturation
- Injection frequency
- Once nightly, 5–7 days/week
- Daily or 5-on-2-off cycling protocols
- GH pulse occurs 90–120 minutes post-injection; food (especially carbohydrates) blunts GH release via insulin spike
- Consistency matters more than dose escalation. Missing doses disrupts pulsatility restoration, reducing cumulative IGF-1 rise
- Reconstitution
- Lyophilized powder mixed with bacteriostatic water (typical ratio 2mL per 5mg vial)
- Store reconstituted solution at 2–8°C; use within 28 days
- Allow vial to reach room temperature before mixing; inject air-free using sterile technique to prevent contamination
- Temperature excursions above 8°C denature the peptide irreversibly. Most protocol failures happen during storage, not administration
- Expected timeline
- IGF-1 rise detectable at 4–6 weeks; body composition changes at 12–16 weeks
- Sleep quality improvement often noted within 2–3 weeks before measurable metabolic changes
- Combine with resistance training 3–4x/week and protein intake ≥1.6g/kg to maximize lean mass preservation
- Women expecting rapid fat loss within the first month misunderstand the mechanism. Sermorelin restores anabolic capacity, it doesn't override caloric balance